Canopy Growth

CGC

Market cap $400M

Cannabis has carved out it's own holiday shopping rush and it's called "Green Wednesday". Behind April 20, the day before Thanksgiving has become the second-biggest day for cannabis sales in the U.S. Brandon Gomez unpacks the new buzzy trend for an age old tradition.

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The U.S. legal cannabis industry is showing strong momentum, and the time may be ripe to scan for promising Canadian-listed stocks. In fact, the U.S. market is projected to reach about US$45 billion in 2025, growing at roughly an 11-12 percent annual rate through the rest of the decade. Meanwhile, public support for reform sits near record levels, and recent headlines highlighted renewed federal attention on descheduling efforts. These developments increased optimism, although uncertainty remains. Consequently, Canadian cannabis companies with U.S. exposure could benefit significantly if policy improves. At the same time, traders should not overlook technical analysis. Reviewing chart patterns, volume behavior, and trend strength can help identify reasonable entries. Furthermore, proper risk management remains essential. Using stop-losses, controlling position size, and avoiding emotional decisions can protect capital in a volatile sector. Thus, identifying the right Canadian cannabis stocks to watch this week becomes increasingly important.

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company's medical cannabis offerings in the region. The formats include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis.

The U.S. cannabis market continues to evolve as new legislative discussions, consumer trends, and business developments shape the industry's momentum. Although volatility remains, investors are increasingly watching leading cannabis companies for signs of stabilization and long-term growth potential. November 2025 brings a renewed focus on recognizable names that continue to push toward profitability, expand product lines, and position themselves for future U.S. federal reform. Meanwhile, market participants continue to closely monitor price action, utilizing technical analysis and disciplined risk management to identify strong investment opportunities. Support and resistance levels remain important as cannabis stocks often experience sharp swings. Therefore, traders must stay patient and selective when approaching the sector. Despite short-term uncertainty, several companies remain compelling due to their strong brands, diversified strategies, and ongoing operational improvements. Below are three top marijuana stocks to watch this month.

Canopy Growth's narrower loss, rising Canadian sales and improving margins signal progress in its turnaround, even as competition and global headwinds persist.

Marijuana Stock investors are keeping a close eye on new market opportunities. With constant shifts in the cannabis industry, forecasting more accurate trading is challenging. The way most pot stocks trade is similar to others in the regard that if one company goes up, others may as well. It is the speculation of what may occur in the grey area industry. Legal operators that make up the industry fight to prove to the public the importance and legitimacy of legal cannabis.

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Canopy Growth reported improved financial results for Q2, with higher revenue and improved net loss. CGC saw an increase in sales of Canadian cannabis, while international cannabis decreased YoY. The stock price is down 68% over the last year.

Canopy Growth Corporation ( WEED:CA ) Q2 2026 Earnings Call November 7, 2025 10:00 AM EST Company Participants Tyler Burns - Director of Investor Relations Luc Mongeau - CEO & Director Thomas Stewart - Chief Accounting Officer & CFO Conference Call Participants William Kirk - ROTH Capital Partners, LLC, Research Division Aaron Grey - Alliance Global Partners, Research Division Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division Pablo Zuanic - Zuanic & Associates Presentation Operator Good morning. My name is Joanna, and I will be your conference operator today.